Breye Therapeutics

About:

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

Website: https://breyetx.com

Top Investors: Novo Holdings, Vaekstfonden, Innovation Fund Denmark, BioInnovation Institute, Sound Bioventures

Description:

Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.

Total Funding Amount:

4M EUR

Headquarters Location:

Denmark, South Carolina, United States

Founded Date:

2015-01-01

Founders:

Ulrik Mouritzen

Number of Employees:

11-50

Last Funding Date:

2022-11-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai